Expression of concern
Antivirus effectiveness of ivermectin on dengue virus type 2 in Aedes albopictus
Paper Information
Record ID:
35016
Author(s):
Journal:
Publication Date:
November 19, 2018
Retraction Date:
January 11, 2022
(3.9 years years ago)
Subjects:
Institutions:
- National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, and National Center for Tropical Diseases Research, Shanghai, the People’s Republic of China
- Key Laboratory of Parasite and Vector Biology, Ministry of Public Health, and WHO Collaborating Centre for Tropical Diseases, Shanghai, the People’s Republic of China
- Nanchang Customs District, and Jiangxi International Travel Healthcare Center, Nanchang, the People’s Republic of China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1371/journal.pntd.0010117Citations (47)
47
Total Citations20
Post-Retraction(42.6%)
26
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
1
Within 30 days
8
Within 1 year
6
After 2+ years
1155
Days since retraction (latest)
Metagenomic exploration of the bacteriome reveals natural<i>Wolbachia</i>infections in yellow fever mosquito<i>Aedes aegypti</i>and Asian tiger mosquito<i>Aedes albopictus</i>
Gul E Nayab, Rafi Ur Rahman, Fazal Hanan et al. (5 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Mar 2025
1155 days after retraction
Avermectins Inhibit Replication of Parvovirus B19 by Disrupting the Interaction Between Importin α and Non-Structural Protein 1
Gualtiero Alvisi, Elisabetta Manaresi, Silvia Pavan et al. (6 authors)
Viruses
Open Access
Published: Feb 2025
1119 days after retraction
Machine learning and molecular docking prediction of potential inhibitors against dengue virus
George W. Hanson, Joseph Adams, Daveson I. B. Kepgang et al. (10 authors)
Frontiers in Chemistry
Open Access
Published: Dec 2024
5 citations
5 citations
1078 days after retraction
New use of praziquantel as a broad-spectrum anti-parasitic agent in blocking MSRV infection
Xu Zhang, Huan Wang, Zixuan Wang et al. (9 authors)
Aquaculture
Published: Nov 2024
1 citation
1 citation
1025 days after retraction
Dengue virus: pathogenesis and potential small molecule antivirals
Navya Chauhan, Kishan Kumar Gaur, Tejeswara Rao Asuru et al. (4 authors)
Bioscience Reports
Open Access
Published: Jul 2024
3 citations
3 citations
926 days after retraction
Development and in vitro antiviral activity of ivermectin liposomes as a potential drug carrier system
Meryem Kocas, Tansel Çomoğlu, Aykut Özkul
Archiv der Pharmazie
Published: May 2024
4 citations
4 citations
843 days after retraction
Praziquantel: A Broad-Spectrum Anthelmintic Compound Unveiling Antiviral Potential Against Msrv, Paving the Way for Novel Applications and Value in Aquaculture
Xu Zhang, Huan Wang, Zixuan Wang et al. (9 authors)
Unknown Journal
Published: Jan 2024
720 days after retraction
Exploring the Targets of Dengue Virus and Designs of Potential Inhibitors
Sayan Nath, P.K. Malakar, Baisakhi Biswas et al. (7 authors)
Combinatorial Chemistry & High Throughput Screening
Published: Nov 2023
2 citations
2 citations
672 days after retraction
Favipiravir and ivermectin show in vitro synergistic antiviral activity against SARS-CoV-2
Kunlakanya Jitobaom, Chompunuch Boonarkart, Suwimon Manopwisedjaroen et al. (8 authors)
Acta Virologica
Open Access
Published: Nov 2023
3 citations
3 citations
660 days after retraction
Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster Model
Takayuki Uematsu, Tomomi Takano, Hidehito Matsui et al. (6 authors)
The Journal of Antibiotics
Open Access
Published: Apr 2023
5 citations
5 citations
469 days after retraction
Importin α/β-dependent nuclear transport of human parvovirus B19 nonstructural protein 1 is essential for viral replication
Gualtiero Alvisi, Elisabetta Manaresi, E.M. Cross et al. (11 authors)
Antiviral Research
Open Access
Published: Mar 2023
15 citations
15 citations
441 days after retraction
Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors
Emmanuel Broni, Carolyn N. Ashley, Joseph Adams et al. (9 authors)
International Journal of Molecular Sciences
Open Access
Published: Mar 2023
17 citations
17 citations
440 days after retraction
Integrated Management of Scabies and Other Parasitic Diseases
Aileen Y. Chang, Jörg Heukelbach
Springer eBooks
Published: Jan 2023
1 citation
1 citation
355 days after retraction
Recent updates on the biological efficacy of approved drugs and potent synthetic compounds against SARS-CoV-2
Anjani Anjani, Sumit Kumar, Brijesh Rathi et al. (4 authors)
RSC Advances
Open Access
Published: Jan 2023
9 citations
9 citations
355 days after retraction
Biologics for dengue prevention: up-to-date
Adam T. Waickman, Krista L. Newell, Timothy P. Endy et al. (4 authors)
Expert Opinion on Biological Therapy
Published: Nov 2022
13 citations
13 citations
316 days after retraction
Prophylactic Effect of Ivermectin on SARS-CoV-2 Induced Disease in a Syrian Hamster Model
Takayuki Uematsu, Tomomi Takano, Hidehito Matsui et al. (5 authors)
Research Square (Research Square)
Open Access
Published: Sep 2022
247 days after retraction
Central Effects of Ivermectin in Alleviation of Covid-19-induced Dysauto-nomia
Αθανάσιος Αλεξίου, Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy et al. (4 authors)
Current Drug Targets
Published: Aug 2022
10 citations
10 citations
212 days after retraction
Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations
Kunlakanya Jitobaom, Chompunuch Boonarkart, Suwimon Manopwisedjaroen et al. (8 authors)
BMC Pharmacology and Toxicology
Open Access
Published: Jun 2022
15 citations
15 citations
158 days after retraction
Forging Ahead the Repositioning of Multitargeted Drug Ivermectin
Srividya Atmakuri, Shweta Nene, Dharmendra Kumar Khatri et al. (6 authors)
Current Drug Delivery
Published: May 2022
2 citations
2 citations
126 days after retraction
Repurposing the drug, ivermectin, in COVID-19: toxicological points of view
Farshad M. Shirazi, Roya Mirzaei, Samaneh Nakhaee et al. (6 authors)
European journal of medical research
Open Access
Published: Feb 2022
17 citations
17 citations
25 days after retraction
Expression of Concern: Antivirus effectiveness of ivermectin on dengue virus type 2 in Aedes albopictus
Unknown Authors
PLoS neglected tropical diseases
Open Access
Published: Jan 2022
Same day as retraction
Evaluation of an ivermectin-based attractive targeted sugar bait (ATSB) against Aedes aegypti in Tanzania.
Frank Tenywa, Jeremiah John Musa, Revocatus Musyangi Musiba et al. (7 authors)
Wellcome Open Research
Open Access
Published: Jan 2022
7 citations
7 citations
6 days before retraction
Antiviral potential of medicinal plants: a case study with guava tree against dengue virus using a metabolomic approach
Thomas Vial, Chiobouaphong Phakeovilay, Satoru Watanabe et al. (9 authors)
Elsevier eBooks
Published: Jan 2022
10 days before retraction
The potential of drug delivery nanosystems to treat COVID-19
Ileana García-Silva, Gabriela Palestino, Omar González‐Ortega
Elsevier eBooks
Published: Oct 2021
1 citation
1 citation
81 days before retraction
Favipiravir and Ivermectin Showed in Vitro Synergistic Antiviral Activity against SARS-CoV-2
Kunlakanya Jitobaom, Chompunuch Boonarkart, Suwimon Manopwisedjaroen et al. (8 authors)
Research Square (Research Square)
Published: Oct 2021
3 citations
3 citations
89 days before retraction
A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status
Apu Chowdhury, Muhammad Sajid, Nabila Jahan et al. (9 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Jul 2021
17 citations
17 citations
168 days before retraction
Controlled Randomized Clinical Trial on Using Ivermectin with Doxycycline for Treating COVID-19 Patients in Baghdad, Iraq
Hashim Hashim, Mohammed Maulood, Chasib Ali et al. (7 authors)
Iraqi journal of Medical Sciences
Open Access
Published: Jun 2021
9 citations
9 citations
195 days before retraction
Tenovin-1 inhibited dengue virus replication through SIRT2
Yihong Wan, Wenyu Wu, Jiawen Zhang et al. (9 authors)
European Journal of Pharmacology
Published: Jun 2021
16 citations
16 citations
208 days before retraction
Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection
Luis Enrique Bermejo Galan, Nayara Melo dos Santos, Mauro Shosuka Asato et al. (19 authors)
Pathogens and Global Health
Open Access
Published: Mar 2021
71 citations
71 citations
309 days before retraction
Emerging therapeutics in the management of COVID-19
Asim Kichloo, Michael Albosta, Akshay Kumar et al. (10 authors)
World Journal of Virology
Open Access
Published: Jan 2021
9 citations
9 citations
355 days before retraction
A systematic review of experimental evidence for antiviral effects of ivermectin and an in silico analysis of ivermectin's possible mode of action against SARS‐CoV‐2
Robert T. Kinobe, Leigh Owens
Fundamental and Clinical Pharmacology
Open Access
Published: Jan 2021
38 citations
38 citations
361 days before retraction
High concentrations of membrane-fed ivermectin are required for substantial lethal and sublethal impacts on Aedes aegypti
Max Hadlett, Sanjay C. Nagi, Manas Sarkar et al. (5 authors)
Parasites & Vectors
Open Access
Published: Jan 2021
16 citations
16 citations
370 days before retraction
Nanotechnology Based Emerging Approaches to Combat Malaria and Dengue Fever
Toqeer Ahmed, Irfan Liaqat, Muhammad Zeeshan Hyder
Advances in medical technologies and clinical practice book series
Published: Jan 2021
2 citations
2 citations
375 days before retraction
Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review
Bruno Silva Andrade, Fernanda de Souza Rangel, Naiane Oliveira Santos et al. (10 authors)
Frontiers in Pharmacology
Open Access
Published: Dec 2020
29 citations
29 citations
393 days before retraction
Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq
Hashim A. Hashim, Mohammed Fauzi Maulood, Anwar M. Rasheed et al. (6 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Oct 2020
90 citations
90 citations
441 days before retraction
Ivermectin: an award-winning drug with expected antiviral activity against COVID-19
Fábio Rocha Formiga, Roger LeBlanc, Juliana de Souza Rebouças et al. (6 authors)
Journal of Controlled Release
Open Access
Published: Oct 2020
79 citations
79 citations
461 days before retraction
Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects
Gaber El‐Saber Batiha, Ali Alqahtani, Omotayo B. Ilesanmi et al. (7 authors)
Pharmaceuticals
Open Access
Published: Aug 2020
171 citations
171 citations
512 days before retraction
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments
Pedram Goodarzi, Farzad Mahdavi, Rasoul Mirzaei et al. (12 authors)
International Immunopharmacology
Open Access
Published: Aug 2020
33 citations
33 citations
521 days before retraction
The Battle against COVID 19 Pandemic: What we Need to Know Before we “Test Fire” Ivermectin
Kushal Banerjee, Manab Nandy, Chanchal Kumar Dalai et al. (4 authors)
Drug Research
Open Access
Published: Jun 2020
25 citations
25 citations
571 days before retraction
Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus
Mohd Ishtiaq Anasir, Babu Ramanathan, Chit Laa Poh
Viruses
Open Access
Published: Mar 2020
46 citations
46 citations
656 days before retraction
Ivermectin Inhibits Bovine Herpesvirus 1 DNA Polymerase Nuclear Import and Interferes With Viral Replication
Sohail Raza, Farzana Shahin, Wenjun Zhai et al. (12 authors)
Microorganisms
Open Access
Published: Mar 2020
51 citations
51 citations
669 days before retraction
The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer
Sundy N.Y. Yang, Sarah C. Atkinson, Chunxiao Wang et al. (7 authors)
Antiviral Research
Published: Mar 2020
303 citations
303 citations
679 days before retraction
Role of ivermectin in COVID-19: Wishful thinking or scientific optimism
Prafull Mohan, Sharmila Sinha, Rajdeep Singh uppal
Journal of Marine Medical Society
Open Access
Published: Jan 2020
741 days before retraction
COVID-19 and Possible Pharmacological Preventive Options
Pontus Dunér, Albert Salehi
Journal of Clinical Medicine Research
Open Access
Published: Jan 2020
6 citations
6 citations
741 days before retraction
Effects of Chinese and Western Medicine on Patients with Dengue Fever
Yu‐Pei Chen, Tzong‐Shiann Ho, Po-Chang Lee et al. (8 authors)
The American Journal of Chinese Medicine
Published: Jan 2020
7 citations
7 citations
741 days before retraction
Viral Appropriation: Laying Claim to Host Nuclear Transport Machinery
Tanner M. Tessier, Mackenzie J. Dodge, Martin A. Prusinkiewicz et al. (4 authors)
Cells
Open Access
Published: Jun 2019
25 citations
25 citations
948 days before retraction
Chikungunya Detection during Dengue Outbreak in Sumatra, Indonesia: Clinical Manifestations and Virological Profile
R. Tedjo Sasmono, Aditya Perkasa, Benediktus Yohan et al. (10 authors)
American Journal of Tropical Medicine and Hygiene
Open Access
Published: Sep 2017
29 citations
29 citations
1568 days before retraction
Quick Stats
Total Citations:
47
Years Since Retraction:
3.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025